SEC Form 4 · accession 0001193125-26-389289
BioStem Technologies, Inc. · BSEM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barry Hassett
Officer — Chief Commercial Officer
Period of report
Sep 9, 2026
Accepted (ET)
Sep 11, 2026 · 4:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001658678
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 9, 2026 | M | 500 | $0.00 | A | 5,003 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF4,F5 | — | Sep 9, 2026 | M | 500 | D | — | — | Common Stock | 500 | 4,497 | D |
| Stock Options (Right to Buy)F1 | $14.89 | holding | — | — | — | — | Feb 1, 2035 | Common Stock | 11,417 | 11,417 | D |
| Stock Options (Right to Buy)F2 | $14.89 | holding | — | — | — | — | Oct 13, 2035 | Common Stock | 2,427 | 2,427 | D |
| Stock Options (Right to Buy)F3 | $5.50 | holding | — | — | — | — | Feb 11, 2036 | Common Stock | 70,485 | 70,485 | D |
| Restricted Stock UnitsF4,F6 | — | holding | — | — | — | — | — | Common Stock | 1,519 | 1,519 | D |
| Restricted Stock UnitsF4,F7 | — | holding | — | — | — | — | — | Common Stock | 58,182 | 58,182 | D |
Explanation of responses
- F1These options vest according to the following schedule: 33% vested on February 1, 2026, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period.
- F2These options vest according to the following schedule: 33%% will vest on October 13, 2026, the one-year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period.
- F3These options vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period.
- F4Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- F5These restricted stock units vest in equal quarterly installments over four years from the grant date (December 9, 2024).
- F6These restricted stock units vest according to the following schedule: 33% vested on February 1, 2026, the one-year anniversary of the grant date, with the remaining unites vesting in equal quarterly installments over the subsequent two year period.
- F7These restricted stock units vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly installments over the subsequent two year period.